These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 239234)

  • 21. Studies on the antibacterial activity of 1-substituted 1,4-dihydro-7-(2-(5-nitro-2-furyl)vinyl)-4-oxo-1,8-naphthyridine derivatives.
    Nagasaki S; Nakazawa N; Osada Y; Hashizume T; Oshima Y
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):639-49. PubMed ID: 5045609
    [No Abstract]   [Full Text] [Related]  

  • 22. 3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies.
    Benitez D; Cabrera M; Hernández P; Boiani L; Lavaggi ML; Di Maio R; Yaluff G; Serna E; Torres S; Ferreira ME; Vera de Bilbao N; Torres E; Pérez-Silanes S; Solano B; Moreno E; Aldana I; López de Ceráin A; Cerecetto H; González M; Monge A
    J Med Chem; 2011 May; 54(10):3624-36. PubMed ID: 21506600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridoquinoxaline N-oxides. 1. A new class of antitrichomonal agents.
    Glazer EA; Chappel LR
    J Med Chem; 1982 Jul; 25(7):766-9. PubMed ID: 7108893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial nitrofuran derivatives. 2. 5-Nitro-2-furaldehyde aminoacethydrazones.
    Massarani E; Nardi D; Tajana A; Degen L
    J Med Chem; 1971 Jul; 14(17):633-5. PubMed ID: 5005988
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimicrobial activity of 3-substituted 5-amino-1,2,4-oxadiazoles.
    Gadebusch HH; Breuer H; Miraglia G; Basch HI; Semar R
    Antimicrob Agents Chemother (Bethesda); 1969; 9():280-3. PubMed ID: 4918994
    [No Abstract]   [Full Text] [Related]  

  • 26. Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships.
    Aguirre G; Cerecetto H; Di Maio R; González M; Alfaro ME; Jaso A; Zarranz B; Ortega MA; Aldana I; Monge-Vega A
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3835-9. PubMed ID: 15203172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piromidic acid, a new antibacterial agent: antibacterial properties.
    Shimizu M; Nakamura S; Takase Y
    Antimicrob Agents Chemother (Bethesda); 1970; 10():117-22. PubMed ID: 4939730
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo antibacterial activity of diaveridine-sulfonamide combinations.
    Carroll PT; Robb CA; Tippett LO; Langston JB
    Invest Urol; 1971 Jul; 9(1):21-4. PubMed ID: 4935215
    [No Abstract]   [Full Text] [Related]  

  • 29. Chloramphenicol for oral treatment of canine urinary tract infections.
    Ling GV; Ruby AL
    J Am Vet Med Assoc; 1978 Apr; 172(8):914-6. PubMed ID: 348660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on furan derivatives. X. Preparation of 2-substituted 3-(5-nitro-2-furyl)guinoxaline 1,4-dioxides and determination of their antibacterial activity.
    Tanaka A; Usui T
    Chem Pharm Bull (Tokyo); 1981 Jan; 29(1):110-5. PubMed ID: 7261188
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibiotic activity in vivo of a staphylococcin produced by a strain of Micrococcus sp].
    Gabbrielli G; Lo Bianco A; Farina W
    Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1890-4. PubMed ID: 4899171
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chemotherapeutic study of ampicillin in experimental infections].
    Petrova MA; Berezina EK; Chavdarova VB
    Antibiotiki; 1968 Sep; 13(9):815-20. PubMed ID: 4884475
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cefazolin. 3. Double blind controlled trial in urinary tract infections].
    Seika K; Minakawa M; Miyoshi K; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1972 Apr; 25(2):72-8. PubMed ID: 4627212
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibacterial nitrofuran derivatives. 3. 5-Nitro-2-furaldehyde piperazinoacylhydrazones.
    Nardi D; Massarani E; Rossi S; Tajana A; Degen L
    J Med Chem; 1971 Jul; 14(17):635-8. PubMed ID: 5005989
    [No Abstract]   [Full Text] [Related]  

  • 36. [Activity of oxolinic acid in some models of experimental infections in the rodents].
    De Pascale V; Cristallo Dormia L; Craveri F; Lecchini S; Frigo GM; Crema A
    Boll Chim Farm; 1974 Mar; 113(3):165-74. PubMed ID: 4602595
    [No Abstract]   [Full Text] [Related]  

  • 37. Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives.
    Abdullah MA; Abuo-Rahma GE; Abdelhafez EM; Hassan HA; Abd El-Baky RM
    Bioorg Chem; 2017 Feb; 70():1-11. PubMed ID: 27908539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitroheterocyclic antimicrobial agents. 1-Methyl-2-nitro-5-imidazolyl derivatives.
    Asato G; Berkelhammer G
    J Med Chem; 1972 Oct; 15(10):1086-8. PubMed ID: 4560746
    [No Abstract]   [Full Text] [Related]  

  • 39. [Epidemiology of the urinary tract infection in patients with prolonged catheterization in an intensive care unit].
    Kolb R; Rotter M
    Anaesthesist; 1973 May; 22(5):239-42. PubMed ID: 4198502
    [No Abstract]   [Full Text] [Related]  

  • 40. [Primary bacterial aortitis].
    Tiesenhausen K; Amann W; Thalhammer M; Koch G
    Zentralbl Chir; 2000; 125(3):275-9. PubMed ID: 10769448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.